Lobbying Information
Subject Matters
- Economic Development
- Health
- Industry
- International Trade
- Research and Development
- Science and Technology
Subject Matter Details
Legislative Proposal, Bill or Resolution, Regulation
- Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations
Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
Policies or Program
- Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.
- Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
- Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
- Policy and Programs
Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Correctional Service of Canada (CSC)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Public Health Agency of Canada (PHAC)
In-house Corporation Details
Description of activities
Gilead Sciences Canada Inc. is the Canadian affiliate of Gilead Sciences inc. Gilead Sciences is a
biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in
areas of unmet need. The company has a focus within the HIV, hepatitis, antiviral agents for pandemic response for COVID-19, inflammatory diseases, oncology and respiratory therapeutic areas.
Responsible officer name and position during the period of this registration
Melissa Koomey,
V.P. and General Manager
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
6711 Mississauga Rd, suite 600
Mississauga, ON L5N 2W3
Canada
Telephone number:
905-363-8001
Ext.
8001
Parent Company Information
- Gilead Siences Inc
-
333 Lakeside Dr
Foster City, CA 94404
United States of America
Subsidiary Beneficiary Information
Gilead Sciences Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Melissa Koomey,
V.P. and General Manager |
No public offices held
- Alison Vanlerberghe,
Sr. Director |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Diane Bigras,
Associate Director |
No public offices held
- Bobby Sutherland,
Sr. Director, Government Affairs |
No public offices held
